Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001844645 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value: $124M (100.0% shares, 0.0% debt)

Holdings (11)

OCS OCULIS HOLDING AG 35.4%
Value $43.78M Shares 2,300,774 Est. Cost $12.64 Unrealized +62.2%
ARQT ARCUTIS BIOTHERAPEUTICS INC 26.8%
Value $33.16M Shares 2,120,508 Est. Cost $11.27 Unrealized +25.0%
PCVX VAXCYTE INC 21.7%
Value $26.84M Shares 710,734 Est. Cost $44.02 Unrealized +81.6%
ZBIO ZENAS BIOPHARMA INC 4.7%
Value $5.819M Shares 736,645 Est. Cost $17.70 Unrealized -55.8%
— INOZYME PHARMA INC 3.3%
Value $4.09M Shares 4,494,851 Est. Cost $10.48 Unrealized —
RXRX RECURSION PHARMACEUTICALS IN 2.5%
Value $3.15M Shares 595,518 Est. Cost $6.72 Unrealized +8.4%
BIOA BIOAGE LABS INC 2.0%
Value $2.457M Shares 653,374 Est. Cost $19.50 Unrealized -76.3%
— RALLYBIO CORP 1.3%
Value $1.563M Shares 2,404,644 Est. Cost $16.97 Unrealized —
— VIGIL NEUROSCIENCE INC 0.8%
Value $998K Shares 560,595 Est. Cost $7.03 Unrealized —
IOBT IO BIOTECH INC 0.8%
Value $942K Shares 864,197 Est. Cost $1.76 Unrealized -46.3%
— BOLT BIOTHERAPEUTICS INC 0.6%
Value $757K Shares 1,891,467 Est. Cost $32.91 Unrealized —